183 related articles for article (PubMed ID: 25273355)
1. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.
Wagemakers A; Mason LM; Oei A; de Wever B; van der Poll T; Bins AD; Hovius JW
Gene Ther; 2014 Dec; 21(12):1051-7. PubMed ID: 25273355
[TBL] [Abstract][Full Text] [Related]
2. Tick-Tattoo: DNA Vaccination Against
Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
Front Immunol; 2021; 12():615011. PubMed ID: 33717102
[TBL] [Abstract][Full Text] [Related]
3. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
[TBL] [Abstract][Full Text] [Related]
5. A new approach to a Lyme disease vaccine.
Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
[TBL] [Abstract][Full Text] [Related]
6. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
[TBL] [Abstract][Full Text] [Related]
7. Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure.
Hodzic E; Feng S; Barthold SW
J Infect Dis; 2000 Feb; 181(2):750-3. PubMed ID: 10669369
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
9. Design and development of a novel vaccine for protection against Lyme borreliosis.
Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
[TBL] [Abstract][Full Text] [Related]
10. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
Comstedt P; Schüler W; Meinke A; Lundberg U
PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
[TBL] [Abstract][Full Text] [Related]
11. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.
Fikrig E; Barthold SW; Persing DH; Sun X; Kantor FS; Flavell RA
J Immunol; 1992 Apr; 148(7):2256-60. PubMed ID: 1545130
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
Jacquet M; Durand J; Rais O; Voordouw MJ
Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
[TBL] [Abstract][Full Text] [Related]
13. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
[TBL] [Abstract][Full Text] [Related]
14. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
Klouwens MJ; Salverda MLM; Trentelman JJ; Ersoz JI; Wagemakers A; Gerritzen MJH; van der Ley PA; Hovius JW
Vaccine; 2021 Apr; 39(18):2561-2567. PubMed ID: 33812741
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.
Poljak A; Comstedt P; Hanner M; Schüler W; Meinke A; Wizel B; Lundberg U
Vaccine; 2012 Jun; 30(29):4398-406. PubMed ID: 22100635
[TBL] [Abstract][Full Text] [Related]
17. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses.
Scheiblhofer S; Weiss R; Dürnberger H; Mostböck S; Breitenbach M; Livey I; Thalhamer J
Microbes Infect; 2003 Sep; 5(11):939-46. PubMed ID: 12941385
[TBL] [Abstract][Full Text] [Related]
18. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
Luke CJ; Carner K; Liang X; Barbour AG
J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
[TBL] [Abstract][Full Text] [Related]
19. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.
Bockenstedt LK; Fikrig E; Barthold SW; Kantor FS; Flavell RA
J Immunol; 1993 Jul; 151(2):900-6. PubMed ID: 8335917
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.
Gern L; Hu CM; Voet P; Hauser P; Lobet Y
Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
